Here’s to More Awards. And More to Life!

Dun & Bradstreet-RBL Bank SME Business Excellence Awards, 2019 

Dun & Bradstreet the world’s leading knowledge provider has been consistently tracking crucial sectors of the Indian Economy for over the two decades. As a part of this endeavor, it has been hosting the “SME Business Excellence Awards” since 2008 to recognize the achievements of Indian SME’s and Mid-Corporate. The 2019 edition of these Awards, in association with the RBL Bank, was held at New Delhi on November 20th, 2019. 

In this context, we are extremely pleased to inform that “Meril Life Sciences Private Limited” was selected and awarded the “Dun & Bradstreet-RBL Bank SME Business Excellence Awards, 2019” for Best Pharmaceuticals Company in Mid-Corporate Segment. 

As Meril is committed to R&D, innovation in manufacturing medical technology, and scientific communication we believe in improving the quality of human life through innovative and advanced healthcare solutions.  

India’s medical device sector is undergoing a drastic transformation, with a new regulatory regime aimed at luring industry backers and priming it for significant growth. We aim to improve the quality of human life through innovative and advanced healthcare solutions. As a medical device manufacturer, we exist to improve the inventiveness in healthcare so that people’s lives are enriched. We continually seek excellence in providing answers to some of medicine’s toughest questions.

Our inclination towards research and development is reflected in our diverse offerings. We ensure that we adhere to the best quality of standards in manufacturing, scientific communication and distribution to deliver path-breaking healthcare products to the world.

We collaborate with physicians and global innovators to identify unmet clinical needs and develop revolutionary therapies. We encourage research and academic collaborations and remain available to interact on exciting opportunities. Our products are made in India with a global perspective. Meril Life Sciences has direct sales and representatives offices in India, Germany, Turkey, the US, China and Brazil and its distribution model is spread over more than 100 countries across continents.

Myval- the Revolution in Medical Device Industry:

On 16th November, 2018, we had introduced the first ever indigenously designed and manufactured Transcatheter Aortic Heart Valve (TAVR) – Myval. With this launch, Meril becomes the First Indian Company to make Transcatheter Aortic Heart Valve Replacement (TAVR) Therapy commercially available on the world stage.

The launch of indigenously developed Myval Transcatheter Heart Valve technology is an assertion of this fundamental belief. For us, it is a proud moment to be the first Indian company to commercially make this therapy available in the country and honored with the title of Best Pharmaceuticals Company.